Dear Reader,

You've just stumbled upon a tiny $10 million biotech about to team up with an absolute powerhouse in the OTC cosmetics sector...

And it's set to go public on the NASDAQ just days from now.

They've discovered how to cure scaring from the human body.

And this tiny biotech is now in talks with MAJOR, global brands for an over-the-counter product that could be the next big thing for cosmetics.

But its applications go far beyond that...

They're able to prevent up to 45% of deaths in the world.

And could CURE autoimmune diseases like Type 1 diabetes.

That's why it won't be a surprise when a major Big Pharma player also partners up with them in the future... potentially Johnson and Johnson or Pfizer.

With one stroke of their pen, they could have their accountants buy out this little biotech. Or simply sign a check for all the supplies of this treatment they could ever want.

And with the FDA approving more treatments than ever and nothing else on the planet like this, it won't be a surprise to see this company hit moonshot potential before it lists on the NASDAQ. You can get in before that happens.

Right now you can get in... before this partnership not only validates this company's innovative approach but also positions the company for rapid growth and market penetration as they go public.

(Even if you're not accredited, you can use this rare investment backdoor - and get in for as little as $1,000).

The implications of this partnership are enormous, as you're about to see.

Best,
Editor